Peter Rahmer - 28 Jul 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Signature
/s/ Brian Adams, as Attorney-in-Fact
Issuer symbol
RLAY
Transactions as of
28 Jul 2025
Net transactions value
-$62,947
Form type
4
Filing time
30 Jul 2025, 16:54:35 UTC
Previous filing
01 Jul 2025
Next filing
30 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rahmer Peter Chief Corporate Develpment Officer C/O RELAY THERAPEUTICS, INC., 60 HAMPSHIRE STREET, CAMBRIDGE /s/ Brian Adams, as Attorney-in-Fact 30 Jul 2025 0001959229

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale $5,083 -1,359 -0.34% $3.74 393,722 28 Jul 2025 Direct F1, F2
transaction RLAY Common Stock Sale $57,864 -15,724 -4% $3.68 377,998 29 Jul 2025 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,506 shares of restricted stock units ("RSUs") on July 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 199,209 shares underlying RSUs.
F3 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,393 shares of RSUs on July 28, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F4 Includes 156,816 shares underlying RSUs.

Remarks:

Chief Corporate Develpment Officer